Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy.
Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy.
复制标题
DOI:
10.1016/j.ijid.2013.07.002
复制
发表时间:
2013-10
期刊:
影响因子:
--
通讯作者:
Al-Tawfiq JA
中科院分区:
文献类型:
--
作者:
Momattin H;Mohammed K;Zumla A;Memish ZA;Al-Tawfiq JA
The Middle East Respiratory Syndrome coronavirus (MERS-CoV) has been detected in a number of countries in the Middle East and Europe with an apparently high mortality rate. It is phylogenetically related to the SARS coronavirus and has also been associated with severe respiratory illness as well as nosocomial transmission in healthcare settings. Current international recommendations do not support any specific therapies; however, there are a number of agents, which were used during the SARS epidemic of 2003. It is possible that these might be active against the related MERS coronavirus. We have reviewed the literature on the safety and efficacy of therapies used in patients with SARS with a view to their potential use in patients with MERS-CoV infections.
登录
查看更多内容
DOI:
10.1007/s10096-004-1271-9
发表时间:
2005-01
期刊:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
影响因子:
--
作者:
Cheng Y;Wong R;Soo YO;Wong WS;Lee CK;Ng MH;Chan P;Wong KC;Leung CB;Cheng G
通讯作者:
Cheng G
影响因子:
3.3
作者:
Leong, HN;Ang, B;Leo, YS
通讯作者:
Leo, YS
影响因子:
15.8
作者:
Stockman LJ;Bellamy R;Garner P
通讯作者:
Garner P
影响因子:
10
作者:
Chu, CM;Cheng, VCC;Yuen, KY
通讯作者:
Yuen, KY
DOI:
10.1056/nejmoa1306742
发表时间:
2013-08-01
期刊:
The New England journal of medicine
影响因子:
--
作者:
Assiri A;McGeer A;Perl TM;Price CS;Al Rabeeah AA;Cummings DA;Alabdullatif ZN;Assad M;Almulhim A;Makhdoom H;Madani H;Alhakeem R;Al-Tawfiq JA;Cotten M;Watson SJ;Kellam P;Zumla AI;Memish ZA;KSA MERS-CoV Investigation Team
通讯作者:
KSA MERS-CoV Investigation Team